[1]
N. Era, S. Mukherjee, B. Saha, and S. K. Tripathi, “Monitoring cutaneous adverse drug reactions in patients on TDF+3TC+EFV: a single centre experience”, Int J Basic Clin Pharmacol, vol. 6, no. 6, pp. 1467–1471, May 2017.